logo

Zentalis Pharmaceuticals Inc (ZNTL) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Zentalis Pharmaceuticals Inc’s current trading price is -89.68% away from its 52-week high, while its distance from the 52-week low is 15.83%. The stock’s price range for this period has been between $1.61 and $18.07 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.28 million for the day, a number notably higher than the average daily volume of 1.78 million over the last three months.

In terms of market performance, Zentalis Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $18.07 on 02/28/24, and the lowest value was recorded at $1.61 on 02/04/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Zentalis Pharmaceuticals Inc (ZNTL) has experienced a quarterly decline of -43.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 132.90M and boasts a workforce of 168 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.1448, with a change in price of -1.3800. Similarly, Zentalis Pharmaceuticals Inc recorded 2,160,590 in trading volume during the last 100 days, posting a change of -42.46%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ZNTL stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.

ZNTL Stock Stochastic Average

As of today, Zentalis Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 10.88%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 16.46%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 7.05% and 5.24%, respectively.

ZNTL Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -38.45% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -45.63%. Over the past 30 days, the price of ZNTL has leaped by -42.44%. And in the last five days, it has fallen by -1.33%.

Most Popular